Negocios · 4/12/20121 min de lectura
Guidance on Investigational New Drug Applications for Positron Emission Tomography Drugs; Availability
Traducción automática local · Idioma original de la fuente
Resumen
The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs." The guidance is intended to assist manufacturers of PET drugs in submitting investigational new drug applications (INDs).